Read More Pharma Industry News Does host-pathway targeting offer a durable COVID-19 strategy for Bioxytran, Inc.? Bioxytran, Inc. reports early ProLectin-M data. Explore what host-targeted antivirals mean for COVID-19 strategy and biotech investors. bySoujanya RaviMarch 5, 2026